Wegovy
ProductHeard on podcasts recently
Wegovy is a brand name for semaglutide, an anti-obesity medication developed by Novo Nordisk for chronic weight management. Administered as a weekly subcutaneous injection, it acts as a GLP-1 receptor agonist to regulate appetite and food intake.
Rank this week
—
Not in this week’s list
Share of the conversation
—
Reach this week
—
Tone this week
—
Not enough signal yet (fewer than 3 episodes scored).
Share of the conversation
Mentions of Wegovy per 1,000 mentions of anything, 7-day rolling, all podcasts.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 5 | 0.16‰ | 1 |
| Aug 12 | 0.04‰ | 1 |
| Aug 13 | 0.07‰ | 1 |
| Aug 14 | 0.09‰ | 1 |
| Aug 16 | 0.12‰ | 1 |
| Aug 17 | 0.16‰ | 1 |
| Aug 18 | 0.19‰ | 1 |
| Aug 21 | 0.21‰ | 3 |
| Aug 24 | 0.18‰ | 1 |
| Aug 31 | 0.03‰ | 1 |
| Sep 1 | 0.06‰ | 1 |
| Sep 2 | 0.10‰ | 1 |
| Sep 3 | 0.12‰ | 1 |
| Sep 4 | 0.16‰ | 1 |
| Sep 8 | 0.14‰ | 1 |
| Sep 11 | 0.07‰ | 1 |
| Sep 13 | 0.14‰ | 2 |
| Sep 21 | 0.06‰ | 2 |
| Sep 22 | 0.08‰ | 1 |
| Sep 25 | 0.11‰ | 1 |
Discussed alongside
Names that come up in the same conversations as Wegovy.
Embed this
Paste this on your site to show Wegovy's current trend:
<iframe src="https://podlume.ai/embed/e/wegovy" width="360" height="220" style="border:0" loading="lazy" title="Wegovy on PodLume Trends"></iframe>